Further information
Weight 110 g
EAN 698545962855
Shipping Method Signed
Typical amount per capsule:
Suggested use:
As a food supplement for adults.
Take 1-2 capsules on an empty stomach daily, or as directed by a healthcare practitioner.
Do not exceed the stated recommended daily dose.
Food supplements should not be used as a substitute for a varied diet.
Forbehold. Enkelte myndigheter utenfor Norge kan anbefale høyere doser vitaminer og andre kosttilskudd enn norske helsemyndigheter tilrår. Vi tar forbehold om at artikler eller lenker vi viser til, kan anbefalinger som ikke er i tråd med norsk regelverk. Uno Vita hevder ikke at produktene vi markedsfører, kan kurere sykdom, selv der dette blir påstått av andre vi kan ha vist til. All bruk av kosttilskudd foregår på eget ansvar og bør skje i samråd med helsefaglig kvalifisert personell. Konsulter din lege om du er i tvil
The evidence
More than 2000 independent, peer-reviewed research papers have been published on the bioactive properties of fucoidan. This extensive body of evidence includes comprehensive in vitro investigations, animal studies and human clinical trials. Research into the therapeutic properties of fucoidan has largely focussed on the six key health indications identified below. The following summary of global research findings is provided for educational and scientific research purposes only.
Extensive research has been undertaken on the immune-modulatory properties of fucoidan. Published papers have reported that fucoidan may exert a range of beneficial effects on the human immune system, including the reduction of allergic responses and the activation of dendritic cells, natural killer cells and T cells. It has also been shown that fucoidan has the potential to boost important anti-viral and anti-tumour responses.
Fucoidan is most widely known and used for its potential anti-cancer properties. A considerable amount of research has been undertaken in this area, with some researchers proposing that fucoidan not only increases patient wellbeing, but also assists in the treatment of disease. The potential for fucoidan as an anti-cancer agent is explored in several review publications, including those by Fitton (2015), Kwak (2014) and Lowenthal (2014).
There is rapidly growing interest in the potential for fucoidan to address a range of human gastric health indications. Published research has already reported a range of beneficial effects of fucoidan on models of digestive function, including the amelioration of debilitating conditions such as colitis and gastric ulcers. Fucoidan also has anti-pathogenic properties that may be beneficial for gastric function, as well as a strong research record in liver and kidney health.
Fucoidan shows potential therapeutic anti-inflammatory activity, particularly as a selectin blocker. Fucoidan has potential to be remarkably effective in addressing systemic inflammation, as well as local inflammation in the digestive tract when orally ingested and on the skin when applied topically. The mechanisms of action may include inhibition of inflammatory enzymes and increased integrity of cellular junctions.
Fucoidan has the potential to support cardiovascular health in a number of ways. The ingestion of certain fucoidans has shown potential to regulate serum lipids and cholesterols, which are key factors in the development of vascular diseases. A recent human clinical study using the polyphenol-rich fucoidan complex, Maritech® Synergy, recorded a statistically significant increase in the ‘good’ cholesterol, HDL, over a 12 week period (Murray 2021). The propensity of fucoidan to reduce cardiovascular damage may be enhanced by the ability of fucoidan to block scavenger receptors on macrophages, which may reduce LDL cholesterol uptake into artery walls (Park, 2016). Research has also demonstrated that fucoidan has potential beneficial effects on blood pressure, coagulation and tissue vascularisation.
manufacturer | Uno Vita AS |
---|---|
Tax Class | Momspliktige varer 15% |
This is the replacement of Upsell Products